
Yohimbe Bark, yohimbine hydrochloride, Johimbe, aphrodine, corynine, quebrachine
Derived from the bark of yohimbe tree native to West Africa. It has been used as an aphrodisiac for several centuries. Marketed as a steroid substitute, yohimbe is also used with other supplements in formulas to enhance athletic performance. The active component, an alkaloid called yohimbine, was tested in clinical studies to treat sexual dysfunction in men and women (5). Oral administration is well tolerated, but long-term toxic effects have not been studied. Yohimbine stimulates the central nervous system and also acts as a monoamine oxidase inhibitor and calcium channel blocker. Thus, it can potentially interact with numerous drugs causing severe adverse effects.
Although yohimbine was shown effective in treating erectile dysfunction in some studies (2) (3) (4) (5), side effects including nervous excitation, tremors, high blood pressure, nausea, and vomiting have been reported.
A one-year prospective study of dietary supplement-related poison control center calls in 2006 showed that clinically significant toxic effects were most frequently reported with yohimbe-containing products (10).
Yohimbine is an alpha2-adrenoreceptor antagonist. It blocks the presynaptic alpha2-adrenergic receptors, increases parasympathomimetic activity, and reduces sympathetic activity (12) (13). Blocking of alpha2-adrenoreceptors results in increased blood supply to cavernous body tissue. It also increases the plasma levels of noradrenaline by increasing noradrenaline release from the sympathetic nervous system. Aphrodisiac activity of yohimbine may be caused by its dilatory effect on genital blood vessels and the enhancement of sensation to genital tissue, and an increased reflex excitability in the sacral region (4).
Preliminary findings also report that yohimbine possesses endothelin-like actions and affects nitric oxide (NO) production in renal circulation (14).
Yohimbine has a rapid onset due to its highly lipophilic property which assists its absorption and crossing of the blood-brain barrier in a short period of time. Peak plasma levels were observed within 10 to 45 minutes of oral administration. The average oral bioavailability is 33% (ranging from 7% to 87%). It is rapidly eliminated with a half-life of 0.58 hr following oral intake (7). Less than 1% of administered yohimbine is excreted unchanged in urine.
Yohimbe is contraindicated in patients with schizophrenia, depression, anxiety, blood pressure, kidney disease, pregnancy, liver disease, angina pectoris, and heart disease (1).
Reported (Oral):
Ernst, E., and Pittler, M. H. Yohimbine for erectile dysfunction: A systematic review and meta-analysis of randomized clinical trials. J. Urol 1998;159(2):433-436.
This review included seven clinical trials that were performed to determine the therapeutic efficacy of yohimbine for erectile dysfunction. The trials indicate yohimbine is clinically effective compared to placebo and the benefits seem to outweigh the risks. There were very few adverse reactions reported. Researchers suggest that yohimbine can be used as a primary intervention in the treatment of erectile dysfunction.
Bottom Line: Yohimbe has been shown effective in treating erectile dysfunction.
Yohimbe is a tree native to West Africa. Yohimbine, an alkaloid derived from the bark of Yohimbe tree, has been used for many years as an aphrodisiac and in the treatment of erectile dysfunction. It can cause side effects including nervous excitation, tremors, high blood pressure, nausea, and vomiting.
Treatment of erectile dysfunction:
In a recent review of several clinical trials, yohimbine was found to be effective compared to placebo in the treatment of erectile dysfunction.